BRIEF published on 08/28/2025 at 07:05, 4 months 23 days ago Sandoz Expands Rivaroxaban Access in Germany Patent Germany Sandoz Rivaroxaban Antithrombotic
PRESS RELEASE published on 08/28/2025 at 07:00, 4 months 23 days ago Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Germany Sandoz Antithrombotic Treatment Rivaroxaban Generic Medicine
Published on 01/21/2026 at 00:30, 51 minutes ago Caledonia Announces Closing of Upsized $150 Million Convertible Senior Notes Offering and Full Exercise of Initial Purchasers' Option to Purchase Additional Notes
Published on 01/20/2026 at 23:35, 1 hour 46 minutes ago Further Shallow High-Grade Assays Infill Tunkillia S1/2 Pits
Published on 01/20/2026 at 23:30, 1 hour 51 minutes ago Correction to Press Release Issued on January 16, 2026 Announcing Closing of $976,000 Non-Brokered Private Placement
Published on 01/20/2026 at 23:20, 2 hours 1 minute ago Pathfinder Ventures Announces $2 Million Non-Brokered Private Placement
Published on 01/20/2026 at 23:00, 2 hours 21 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Due Diligence Review
Published on 01/21/2026 at 00:50, 31 minutes ago T.D. Williamson launches SHiiELD™ double independent isolation and bleed system
Published on 01/20/2026 at 20:00, 5 hours 21 minutes ago Purchase of all outstanding Bell Group N.V. notes CH0005575151, GB0040901711 and XS0000001247
Published on 01/20/2026 at 19:19, 6 hours 1 minute ago Fuller, Smith & Turner PLC: Transaction in own shares – conclusion and extension of buyback programme
Published on 01/20/2026 at 18:05, 7 hours 16 minutes ago PRC-Saltillo Announces Acquisition of Therapy Box® Apps, Enhancing AAC Communication Options Worldwide
Published on 01/20/2026 at 16:15, 9 hours 6 minutes ago Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
Published on 01/20/2026 at 17:59, 7 hours 21 minutes ago Statement of transactions in own shares from January 14, 2026 to January 16, 2026
Published on 01/20/2026 at 07:30, 17 hours 51 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/19/2026 at 17:35, 1 day 7 hours ago EURAZEO ENTERS INTO AN EXCLUSIVE AGREEMENT WITH L CATTERTON FOR THE SALE OF ITS MINORITY STAKE IN EX NIHILO
